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Abstract
Background: Atrio-esophageal fistula formation following radiofrequency ablation of left atrial tachyarrhythmias is
a rare but devastating complication. Esophageal injuries are believed to be precursors of fistula formation and
reported to occur in up to 47% of patients. This study investigates the incidence of esophageal lesions when real
time esophageal temperature monitoring and temperature limitation is used.
Methods: 184 consecutive patients underwent open irrigated radiofrequency ablation of left atrial
tachyarrhythmias. An esophageal temperature probe consisting of three independent thermocouples was used for
temperature monitoring. A temperature limit of 40°C was defined to interrupt energy delivery. All patients
underwent esophageal endoscopy the next day.
Results: Endoscopy revealed ulcer formation in 3/184 patients (1.6%). No patient developed atrio-esophageal
fistula. Patient and disease characteristics had no influence on ulcer formation. The temperature threshold of 40°C
was reached in 157/184 patients. A temperature overshoot after cessation of energy delivery was observed
frequently. The mean maximal temperature was 40.8°C. Using a multiple regression analysis creating a box lesion
that implies superior- and inferior lines at the posterior wall connecting the right and left encircling was an
independent predictor of temperature. Six month follow-up showed an overall success rate of 78% documented as
sinus rhythm in seven-day holter ECG.
Conclusion: Limitation of esophageal temperature to 40°C is associated with the lowest incidence of esophageal
lesion formation published so far. This approach may contribute to increase the safety profile of radiofrequency
ablation in the left atrium.
Background
Pulmonary vein antrum isolation using radiofrequency
ablation has become an effective therapy in symptomatic
patients with atrial fibrillation. Additional linear ablation
in the left atrium is performed in persistent atrial fibril-
lation and atrial flutter. Non-lethal complications such
as cardiac perforation, stroke and pulmonary vein steno-
sis have been reported to occur with rates of 1.3%, 0.2%
and 1.3% respectively [1,2]. A recently reported compli-
cation describes esophageal injury leading to left atrial
esophageal fistula. Despite its low incidence (0.03-0.1%)
this usually lethal complication is of tremendous clinical
importance [3-7]. Other serious esophageal injuries
include vagus nerve damage with acute pyloric spasm
and gastro-paresis [8]. Different strategies are proposed
to avoid esophageal injury. Power and temperature set-
tings are limited when ablating at the posterior wall of
the left atrium [9]. Visualization of the esophagus by
barium swallow or tagging the course of the esophagus
by electro-anatomical mapping has been proposed in
order to modify ablation lines in areas of close proxi-
mity to the esophagus [10]. A pilot study using an irri-
gated intraesophageal cooling balloon resulted in a * Correspondence: armin.sause@helios-kliniken.de
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perature [11,12].
Post ablation esophageal wall changes (erosion or
ulceration) are reported to occur in up to 47% of
patients [13]. Real time temperature monitoring can
detect rapid esophageal heating during radiofrequency
ablation [14].
The aim of this prospective study was to investigate
the incidence of thermal esophageal lesions when limit-
ing the intraluminal esophageal temperature in radiofre-
quency ablation of left atrial tachyarrhythmias.
Methods
Study population
184 consecutive patients with symptomatic atrial fibrilla-
tion or left atrial macro-reentrant tachyarrhythmias
scheduled for ablation were included in this study. All
procedures were performed after obtaining written
informed consent approved by the institutional ethics
committee.
Pulmonary vein isolation
Radiofrequency ablation was performed in conscious
sedation (continuous intravenous injection of propofol
and intravenous injection of fentanyl) or general anaes-
thesia (10 patients). All patients underwent a pre-proce-
dural magnetic resonance imaging or a computed
tomography scan (13 patients) of the left atrium. A
transesophageal echocardiogram was performed within
48 hours prior to the procedure to exclude left atrial
thrombi and visualize the intraatrial septum. Using a
transfemoral venous approach a multipolar catheter was
introduced into the coronary sinus. Transseptal punc-
ture was performed under fluoroscopic guidance using a
steerable long sheath (Agilis, St. Jude Medical, Saint
P a u l ,M N ,U S A ) ,a n daB r o c k e n brough needle. Intrave-
nous unfractionated heparin was administered in boli
immediately following transseptal puncture to maintain
an activated clotting time of 250-350 s. An anatomic
map of the left atrium and the pulmonary veins was cre-
ated using either the NavX-Ensite system (Endocardial
Solutions, St. Paul, USA) in 153 patients or the CARTO
XP system (Biosense Webster, Diamond Bar, CA, USA)
in 31 patients. The segmented MRI or CT image of the
left atrium was fused with the anatomic map using
either the Verismo (Endocardial Solutions, Saint Paul,
MN, USA) or CARTO Merge (Biosense Websters, Dia-
mond Bar, CA, USA) software.
A 7F esophageal temperature probe (Esotherm, Fiab,
Florence, Italy) with 3 consecutive olive shaped thermo-
couples (distance 10 mm) was inserted orally and
advanced into the esophagus. The probe was positioned
directly posterior to the left atrium using the NavX-
Ensite system or fluoroscopic guidance. The course of
the esophagus in relation to the pulmonary venous ostia
was described and classified in five groups similar to
Kottkamp [10]: Right pulmonary vein (RPV)/RPV
ostium/mid posterior wall/left pulmonary vein (LPV)
ostium/LPV. In case of an oblique course classification
was according to the major course and the area with the
least distance to the left atrial wall.
Radiofrequency impulses were delivered circumferen-
tially around each pair of veins approximately 1 cm dis-
tal of the ostia using an open irrigated tip ablation
catheter (IBI coolpath duo; St. Jude Medical, Saint Paul,
MN, USA or Navistar thermocool, Biosense Webster,
Diamond Bar, CA, USA). Guided by the temperature
probe ablation directly adjacent the esophagus was
avoided if possible. Radiofrequency generator settings
were as follows: 40 Watt, 48°C, flow rate 30 ml/min.
When ablating at the posterior wall of the left atrium
power was generally reduced to 30 Watt. The ablation
catheter was held in position until local signal reduction
occurred. However, the catheter was moved at least
every 20 seconds.
During energy delivery the position of the tempera-
ture probe was adjusted in a cranio-caudal manner to
insure minimal distance of the thermocouples to the tip
of the ablation catheter. Figure 1 demonstrates a NavX-
Ensite procedure with a fused MRI of the left atrium.
The operator continuously monitored esophageal tem-
perature of all 3 thermocouples. When temperature
exceeded 40°C ablation was stopped until temperature
normalized. Further ablation could be performed using
less energy to prevent additional temperature rise. In
case of repeated esophageal temperature rise wide encir-
cling or a box lesion (posterior roof- and bottom-line
connecting the anterior encircling of the right and left
pulmonary veins) could be performed at the operator’s
choice.
In paroxysmal atrial fibrillation pulmonary vein isola-
tion was considered to be sufficient, whereas in persis-
tent atrial fibrillation a roof-line and a left atrial
isthmus-line connecting the left inferior pulmonary vein
and the mitral isthmus could be drawn at the operator’s
preference.
In left atrial macro-reentrant tachycardia entrainment
pacing and activation mapping determined the reentrant
circuit. In case of previous pulmonary vein isolation
procedure the veins were checked for isolation first. If
re-connection was documented pulmonary vein re-isola-
tion was performed. Further linear lesions were added
to interrupt the macro-reentry when needed.
All veins were checked for isolation with a steerable cir-
cumferential decapolar catheter. Bidirectional block evi-
denced as disappearance of pulmonary vein potentials and
exit block when pacing inside the vein with maximum
output (10 V/2 ms) confirmed pulmonary vein isolation.
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In patients with clinical suspicion of gastro-esophageal
reflux disease pre-ablation endoscopy was performed.
Ablation was postponed in case of the gastroenterolo-
gist’s recommendation. No routine endoscopy was per-
formed prior to ablation. All patients underwent
endoscopy the day after ablation. Esophageal mucosa at
the anterior wall of the mid-esophagus adjacent to the
left atrial posterior wall was defined as normal, erythema
or ulceration. Any additional follow-up was performed
at the gastroenterologist’s discretion.
Follow-Up
Patients were seen in an outpatient clinic for follow-up
at three and six months or whenever symptoms
occurred. Seven-day Holter ECG was performed at three
and six months. Cardiac MRI or trans-esophageal echo-
cardiogram was carried out at six months to exclude
pulmonary vein stenosis.
Oral anticoagulation was maintained for at least three
months following ablation and according to the
CHADS2 score thereafter.
Statistical analysis
All analyses were performed using SPSS statistical soft-
ware (SPSS 17.0, Chicago, IL). The data are presented as
mean ± SD unless otherwise specified. An a =0 . 0 5w a s
considered statistically significant. Comparison of 2
groups was performed by 1-way analysis of variance
(ANOVA). We first analyzed associations without any
adjustments and then with adjustments for potential
confounders by logistic regression for categorical
variables.
Results
Patient demographics (age, sex), disease characteristics
(type of arrhythmia, underlying heart disease, left ventri-
cular ejection fraction, left atrial size, number of ineffec-
tive antiarrhythmic drugs and index versus redo ablation
procedure) are shown in table 1.
Preablation endoscopy was performed in 23 of 184
patients. Eight patients showed mild reflux disease, three
patients hemorrhagic gastritis, and four patients pyloric
ulcers. All patients were treated with proton pump inhi-
bitors. Ablation was postponed in all patients with
hemorrhagic gastritis and pyloric ulcers until healing
was confirmed. Eight patients had no pathologies on
pre-ablation endoscopy.
The temperature threshold of 40°C was reached in 157
of 184 patients (85%). Despite stopping energy delivery
further increase in esophageal temperature was observed.
This temperature overshoot was registered in 146 of 157
patients (93%) in whom energy delivery was stopped due
to esophageal temperature rise. The mean maximal
recorded temperature was 40.8°C in all patients. The
maximal recorded temperature was 45.3°C in one patient.
Figure 1 Ensite NavX procedure with fused MRI of the left atrium. Temperature probe (orange), ablation catheter (white), coronary sinus
catheter (yellow).
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lesion, roof-line, mitral-isthmus-line, course of the esopha-
gus, type of arrhythmia and index procedure, box lesion
(Beta = 0.29, p = 0.004) remains a significant predictor
variable of maximal esophageal temperature. Figure 2
illustrates the mean maximal temperature in patients with
and without box lesion. Although the course of the eso-
phagus turned out not being an independent predictor of
max temperature, post hoc Bonferroni analysis showed a
significantly higher max temperature in the LPV ostia
group and the RPV ostia group as compared to the mid
posterior left atrium group (table 2). No patient reported
about thoracic discomfort such as dysphagia or odynopha-
gia following ablation. Endoscopy showed thermal ulcera-
tions at the anterior wall in the mid esophagus in three
patients. This was the index pulmonary vein isolation pro-
cedure to treat paroxysmal atrial fibrillation in all three
patients. Table 3 summarizes the procedural findings in
patients with esophageal ulcerations.
An endoscopic picture of the esophageal ulceration in
p a t i e n to n ei ss h o w ni nf i g u r e3 .L e s i o nr e g r e s s i o nw a s
documented after four to six days and complete lesion
healing confirmed after two weeks in all three patients.
No patient developed clinical signs of atrio-esophageal
fistula on follow-up. Patient, disease and procedural
characteristics had no influence on the incidence of eso-
phageal ulcer formation (table 4).
Complication and follow-up
There were two pericardial tamponades that could be
successfully drained with pericardiocentesis. One patient
experienced transitory ischemic attack five days after the
procedure. One patient showed an asymptomatic 50%
stenosis of the left inferior pulmonary vein at six
months follow-up.
A blanking period of six weeks after ablation was
defined. Arrhythmia recurrence in this period was not
considered failure of the procedure. The overall success
rate was 78% (145/184 patients). Seven-day holter ECG
at six months follow-up confirmed sinus rhythm in 125
of 184 patients off anti-arrhythmic drugs. 20 patients
Table 1 Patient and disease characteristics
Patient and disease characteristics
Patients (n) 184
Male (n) 140
Age (years) 58 ± 12
Left atrial parasternal diameter (mm) 42 ± 4.9
Left ventricular ejection fraction (%) 56 ± 16
Paroxysmal atrial fibrillation (n) 129
Persistent atrial fibrillation (n) 43
Left atrial macro-reentrant tachycardia (n) 12
Ineffective antiarrhythmic drugs (n)
None 27
One 117
Two 30
Three 10
Underlying heart disease (n)
None 41
Arterial Hypertension 115
Coronary artery disease 21
Dilative cardiomyopathy 13
Index ablation procedure (n) 122
Figure 2 Mean maximal esophageal temperature (°C) in patients with and without box lesion. *significant p < 0,05.
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ineffective anti-arrhythmic medication.
Discussion
Atrio-esophageal fistula is a rare but devastating compli-
cation of radiofrequency ablation in the left atrium.
Thermal esophageal lesions are believed to be precur-
sors of fistula formation. Little is known about the inci-
dence of thermal esophageal lesions. In most studies
less than 100 patients are included and different ablation
protocols are used [13,15,16].
Recently Halm reported of 185 patients undergoing
left atrial ablation using an open irrigated tip ablation
catheter with 30 Watts at the posterior wall. Esophageal
temperature monitoring without temperature limitation
was utilized. Post-procedural endoscopy of the esopha-
gus revealed ulcer like thermal lesions in 14.6% of
patients [17]. Our series of 184 consecutive patients
showed an incidence of 1.6% thermal esophageal injury.
This is the lowest rate of esophageal lesion formation
described so far. No progression to atrio-esophageal fis-
tula occurred. An intraesophageal temperature limit of
40°C appears to be an effective means of reducing the
incidence of thermal esophageal damage. Halm did not
use a temperature limit and consequently the measured
mean maximal temperature was higher than in our ser-
ies (42.6 ± 1.7°C vs 41.6 ± 1.5°C in patients with ulcers
and 41.4 ± 1.7 vs 40.8 ± 1.8°C in patients without
ulcers). In accordance to their findings we did not detect
ulcers on endoscopy when the maximal temperature
stayed below 41°C.
We decided to use the esotherm temperature probe,
because it consists of three independent thermocouples
with rapid temperature detection capacities. Singh used
a different temperature probe with a single thermocou-
ple in 67 patients. When limiting the temperature to
38.5°C they observed 6% ulcerations as compared to
36% without temperature monitoring [15]. It is of great
importance to ensure a minimal distance between the
temperature probe and the ablation catheter. Using a
probe with three thermocouples significantly reduces
the chance of missing a temperature rise. In addition
the NavX-Ensite system continuously displays the posi-
tion of the thermocouples in relation to the ablation
catheter without the need of fluoroscopy. Ablation
directly adjacent to the presumed course of the esopha-
gus was avoided if possible in our study. In spite of
applying a lower esophageal temperature limit the
higher incidence of ulcerations in the series by Singh
could be explained by these differences. However, Singh
also used a different ablation protocol with 35 Watts at
the posterior wall of the left atrium. This also increases
the likelihood of esophageal lesion formation.
Martinek found a total of 2.9% esophageal lesions in
175 patients. Using a maximal power of 25 Watt with-
out esophageal temperature monitoring, additional abla-
tion lines especially an inferior ablation line parallel to
the coronary sinus were variables favouring the inci-
dence of esophageal lesions [18]. We could not find a
significant correlation of ulcer formation with additional
lines or other variables.
The tissue separating the posterior left atrium from
the anterior esophageal wall is less than 5 millimetres at
its thinnest location [19]. A rapid heat transfer is
described [14]. Even though we applied a temperature
limit of 40°C a temperature overshoot was observed fre-
quently. The mean maximal esophageal temperature
was higher in patients with ulcer formation than in
patients without ulcers (41.6°C ± 1.5°C versus 40.8°C ±
1.8°C). However, this difference was not significant, pos-
sibly due to the low incidence of lesions. Using a multi-
ple linear regression analysis including roof line, box
l e s i o n ,m i t r a li s t h m u sl i n e ,t y p eo fa r r h y t h m i a ,r e d o
procedure and course of the esophagus, creating a
box-lesion predicted a significant higher esophageal
temperature. The box lesion implies an inferior-poster-
ior line connecting the anterior encircling of the right
and left pulmonary veins. In this area the esophagus
Table 2 Esophageal course and maximal esophageal temperature
Esophageal course LPV LPV Ostia Mid posterior left atrium RPV Ostia RPV Total p value
Total number (%) 19 (10%) 76 (41%) 35 (19%) 49 (27%) 5 (3%) 184
Mean maximal temperature (°C) 40.0 ± 2.8* 41.2 ± 1.6# 40.1 ± 1.8#,+ 41.2 ± 1.4*,+ 40.8 ± 1.8* 40.8 ± 1.8 0.005*
Post hoc Test Bonferroni #p = 0.021 +p = 0.039
*significant p < 0,05.
Table 3 Procedural findings in patients with esophageal ulceration
Esophageal course Maximal esophageal temperature (°C) Power reduction (Watts) Ablation procedure
Patient 1 Mid posterior left atrium 41.1 30 PVI without additional linear ablation
Patient 2 Right pulmonary vein ostium 43.5 20 PVI without additional linear ablation
Patient 3 Right pulmonary vein ostium 42.0 30 PVI without additional linear ablation
PVI: Pulmonary Vein Isolation
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terior wall.
As stated before the course of the esophagus along the
left atrial posterior wall is not an independent predictor
of max temperature. However, post hoc Bonferroni ana-
lysis revealed a significant higher temperature of 41.2°C
in patients with close relationship to either the right or
left pulmonary venous ostia as compared to 40.1°C
when the esophagus took a course along the mid poster-
ior left atrium.
Although the temperature limit could not be adhered
to in most cases due to rapid heat transfer it might be
speculated that without this limit even more energy had
been applied resulting in more or greater esophageal
lesions and eventually an increasing risk of atrio-
esophageal fistula formation.
Limitations
Since endoscopy was not routinely performed prior to
ablation it can only be assumed that the described
ulcerations in the mid esophagus at the anterior wall are
caused by thermal damage. However the typical location
far distant from the gastro-esophageal junction makes
other causes unlikely.
The diameter of the esophagus by far exceeds the dia-
meter of the temperature probe. An eccentric placement
of the probe could lead to an underestimation of eso-
phageal temperature [20]. Furthermore esophageal lumi-
nal temperature underestimates esophageal tissue
temperature [21]. Using any luminal temperature limit
can thus not prevent tissue overheating. Since the tem-
perature limit was not used to up-titrate power but
rather to reduce time and energy delivery there was no
danger to inadvertently increase energy delivery.
Conclusions
Limitation of esophageal temperature in radiofrequency
ablation of left atrial tachyarrhythmias is associated with
the lowest incidence of esophageal lesion formation
described until today. Temperature overshoot after ces-
sation of energy delivery is frequent. A posterior box
lesion significantly increases the maximal temperatures
in the esophagus. Follow-up visits including 7 day holter
recordings showed no evidence of reduced efficacy.
Adding temperature limita t i o ni nt h ee s o p h a g u st oa
standard protocol when ablating at the posterior wall of
the left atrium may contribute to increase the safety
profile of the procedure.
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